Review
doi: 10.1016/s0959-4388(00)00253-1.
The cell biology of Alzheimer's disease: uncovering the secrets of secretases
Affiliations
- PMID: 11595492
- DOI: 10.1016/s0959-4388(00)00253-1
Item in Clipboard
Review
The cell biology of Alzheimer's disease: uncovering the secrets of secretases
Curr Opin Neurobiol.
2001 Oct.
Abstract
Progress has been made in characterizing the secretases involved in endoproteolytic processing of the beta-amyloid precursor protein - the precursor of the amyloid beta-peptide (Abeta), which is the main constituent of amyloid plaques that form in the brains of patients with Alzheimer's disease. It is now thought that Abeta is pivotal in the pathogenesis of Alzheimer's disease, and that reducing brain Abeta levels may help to treat or prevent the disease. Two essential factors for the proteolytic generation of Abeta have been identified, beta-secretase and the presenilins, which might aid the design of drugs against this disease.
Similar articles
-
[Secretases as therapeutic targets for the treatment of Alzheimer's disease].Verh K Acad Geneeskd Belg. 2004;66(1):29-58; discussion 58-9. Verh K Acad Geneeskd Belg. 2004. PMID: 15074081 Review. German.
-
BACE1: the beta-secretase enzyme in Alzheimer's disease.J Mol Neurosci. 2004;23(1-2):105-14. doi: 10.1385/JMN:23:1-2:105. J Mol Neurosci. 2004. PMID: 15126696 Review.
-
Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.Eur J Neurosci. 2013 Jun;37(12):1962-9. doi: 10.1111/ejn.12235. Eur J Neurosci. 2013. PMID: 23773065
-
Secretases as targets for the treatment of Alzheimer's disease.Mol Med Today. 2000 Oct;6(10):392-7. doi: 10.1016/s1357-4310(00)01759-7. Mol Med Today. 2000. PMID: 11006528 Review.
-
In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase.Trends Neurosci. 2000 Nov;23(11):565-70. doi: 10.1016/s0166-2236(00)01647-7. Trends Neurosci. 2000. PMID: 11074266 Review.
Cited by
-
Evaluation of neural damage in Duchenne muscular dystrophy patients.Acta Myol. 2014 May;33(1):13-8. Acta Myol. 2014. PMID: 24843230 Free PMC article.
-
Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease.Hum Vaccin Immunother. 2013 Aug;9(8):1643-53. doi: 10.4161/hv.24830. Epub 2013 May 31. Hum Vaccin Immunother. 2013. PMID: 23732905 Free PMC article.
-
BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin.J Biol Chem. 2011 Apr 8;286(14):12602-16. doi: 10.1074/jbc.M110.170217. Epub 2011 Jan 18. J Biol Chem. 2011. PMID: 21245145 Free PMC article.
-
Early Contextual Fear Memory Deficits in a Double-Transgenic Amyloid-β Precursor Protein/Presenilin 2 Mouse Model of Alzheimer's Disease.Int J Alzheimers Dis. 2017;2017:8584205. doi: 10.1155/2017/8584205. Epub 2017 Nov 27. Int J Alzheimers Dis. 2017. PMID: 29333315 Free PMC article.
-
Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein.J Biol Chem. 2016 May 13;291(20):10528-40. doi: 10.1074/jbc.M116.719286. Epub 2016 Mar 8. J Biol Chem. 2016. PMID: 26957541 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
